Kawauchi K, Sugiyama H, Watanabe H, Urabe A, Takaku F
Department of Internal Medicine, Tokyo Women's Medical College, Daini Hospital.
Rinsho Ketsueki. 1990 Jan;31(1):10-5.
Four patients with severe aplastic anemia and one patient with pure red cell aplasia (PRCA) were treated with antilymphocyte and antithymocyte globulins. One patient in aplastic anemia who achieved good response by ALG administration had a possible diagnosis of myelodysplastic syndrome. ATG was administered to only one case of aplastic anemia and ALG was administered to the remainder. In the result, three out of 4 patients with aplastic anemia and one patient with PRCA achieved good response without severe side effects. Three patients with aplastic anemia had high CD4/CD8 ratio in their peripheral lymphocytes. This ratio normalized after ALG therapy in effective cases, but not in ineffective case. Natural killer activity elevated after ALG therapy in two effective cases of aplastic anemia and PRCA, but not in one ineffective case of aplastic anemia.
4例重型再生障碍性贫血患者和1例纯红细胞再生障碍性贫血(PRCA)患者接受了抗淋巴细胞球蛋白和抗胸腺细胞球蛋白治疗。1例接受抗淋巴细胞球蛋白(ALG)治疗后获得良好反应的再生障碍性贫血患者可能诊断为骨髓增生异常综合征。仅1例再生障碍性贫血患者接受了抗胸腺细胞球蛋白(ATG)治疗,其余患者接受了ALG治疗。结果,4例再生障碍性贫血患者中有3例以及1例PRCA患者获得了良好反应,且无严重副作用。3例再生障碍性贫血患者外周淋巴细胞中CD4/CD8比值较高。在有效病例中,ALG治疗后该比值恢复正常,但无效病例未恢复正常。在2例再生障碍性贫血和PRCA的有效病例中,ALG治疗后自然杀伤活性升高,但1例再生障碍性贫血无效病例未升高。